In this week’s Scientist Highlights, we feature Celestina Barbosa-Leiker, PhD who became an Native Alzheimer’s Disease Resource Center for Minority Aging Research (NAD-RCMAR) scientist in 2019. Her research has demonstrated sex differences in the measurement of opioid withdrawal, relapse while in treatment, and predictors of relapse. She is currently leading an interdisciplinary research team to assess mothers, infants, and healthcare providers in order to better care for women with opioid use disorders, as well as for women using cannabis during pregnancy.

Read Dr. Barbosa-Leiker’s bio.

Q&A With Celestina Barbosa-Leiker.

Native Alzheimer’s Disease Resource Center for Minority Aging Research (NAD-RCMAR) is a collaborative program of the following universities:
Washington State University
University of Colorado, Denver
Stanford University